BridgeLine · Tools · Investor · Buy-Side Rapid Screen
Score a deal across 6 dimensions, tag risks with the standard 5-label vocabulary, and generate a 2-3 page T1 memo - GO/NO-GO decision in under 48 hours. Built for VCs and pharma BD teams
Enter basic information about the deal you are evaluating. Fields pre-filled from prior BridgeLine tools where available.
Company name is required to continue.
Continue your analysis by handing off to the next tool in the workflow. Your program data carries forward automatically.
BridgeLine · V8.0 Offer
Independent translational diligence for VCs, pharma BD, and incubators: risk register, kill/pivot/proceed triggers, memo.
Price
$1,500-10,000+
Price
$1,500-10,000+
Timeline
Scoped per engagement
Fixed-fee scope based on target count and depth. Delivery-triggered payment.
Book a Strategy Call§ / Engage
BridgeLine's Buy-Side Diligence service escalates from this rapid screen to an IC-ready T2 memo with SME review, KOL calls, and a full risk register - built to the standard we applied evaluating transactions up to $11B